{"name":"BonusBio Group Ltd","slug":"bonusbio-group-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"BonoFill-II","genericName":"BonoFill-II","slug":"bonofill-ii","indication":"Other","status":"phase_1"},{"name":"MesenCure","genericName":"MesenCure","slug":"mesencure","indication":"Indication under investigation in Phase 3 (specific indication not publicly confirmed)","status":"phase_3"}]}],"pipeline":[{"name":"BonoFill-II","genericName":"BonoFill-II","slug":"bonofill-ii","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"MesenCure","genericName":"MesenCure","slug":"mesencure","phase":"phase_3","mechanism":"MesenCure is a mesenchymal stem cell-based therapy designed to promote tissue regeneration and reduce inflammation through paracrine signaling.","indications":["Indication under investigation in Phase 3 (specific indication not publicly confirmed)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}